0000950116-01-500941.txt : 20011010
0000950116-01-500941.hdr.sgml : 20011010
ACCESSION NUMBER: 0000950116-01-500941
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20011002
ITEM INFORMATION: Other events
ITEM INFORMATION: Change in fiscal year
FILED AS OF DATE: 20011005
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMERICAN BIO MEDICA CORP
CENTRAL INDEX KEY: 0000896747
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141702188
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0430
FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28666
FILM NUMBER: 1753326
BUSINESS ADDRESS:
STREET 1: 122 SMITH ROAD
CITY: KINDERHOOK
STATE: NY
ZIP: 12106
BUSINESS PHONE: 8002271243
MAIL ADDRESS:
STREET 1: 122 SMITH ROAD
CITY: KINDERHOOK
STATE: NY
ZIP: 12106
8-K
1
eight-k.txt
8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 2, 2001
AMERICAN BIO MEDICA CORPORATION
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
New York 0-28666 14-1702188
---------------------------- ------------------------ ----------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
122 Smith Road, Kinderhook, NY 12106
---------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (800) 227-1243
ITEM 5. OTHER EVENTS
On October 2, 2001 the Board of Directors of the registrant accepted
the resignation of Stan Cipkowski as President and Cipkowski was appointed to
the position of Executive Vice President of the registrant. Cipkowski also
remains a Director of the registrant. Robert L. Aromando Jr. was named President
and remains Chief Executive Officer and resigned from his position of Chairman
of the Board of Directors. Aromando also remains as a Director of the
registrant. Gerald Moore, a current Director of the registrant, was elected
Chairman of the Board of Directors.
On October 2, 2001, the shareholders of the registrant ratified the
proposal to allow the registrant to increase its authorized capital stock from
Thirty Million (30,000,000) shares of $0.01 par value common stock to Fifty
Million (50,000,000) shares of $0.01 par value common stock. There was no change
to the current issued and outstanding stock as a result of this action and all
shareholder rights and preferences remain the same.
ITEM 8. CHANGE IN FISCAL YEAR
On October 2, 2001, the Board of Directors of the registrant determined
to change its fiscal year end from April 30, which was the fiscal year used in
its most recent filing with the Commission, to December 31. The report covering
the eight-month transition period ending December 31, 2001, will be filed with
the Commission on Form 10-KSB.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMERICAN BIO MEDICA CORPORATION
(Registrant)
Dated: October 5, 2001 By: /s/ Keith E. Palmer
-----------------------------
Keith E. Palmer
Chief Financial Officer
3